Management of anticoagulation in patients undergoing leadless pacemaker implantation
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 16 (12) , 1849-1854
Abstract
No abstract availableKeywords
Funding Information
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2017_SGR_1548)
- Instituto de Salud Carlos III (PI16/00435, PI16/00703)
- Horizon 2020 (633196)
This publication has 19 references indexed in Scilit:
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSEP Europace, 2016
- A Leadless Intracardiac Transcatheter Pacing SystemNew England Journal of Medicine, 2016
- Early performance of a miniaturized leadless cardiac pacemaker: the Micra Transcatheter Pacing StudyEuropean Heart Journal, 2015
- Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in DenmarkEuropean Heart Journal, 2013
- 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)EP Europace, 2013
- Pacemaker or Defibrillator Surgery without Interruption of AnticoagulationNew England Journal of Medicine, 2013
- HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode SelectionJACC, 2012
- Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trialEuropean Heart Journal, 2009
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantationJACC, 2000